
Drilling down on obesity drugs: What medtech executives are saying
Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Strong patient interest in GLP-1 drugs to
Listen to the article 6 min This audio is auto-generated. Please let us know if you have feedback. Strong patient interest in GLP-1 drugs to
Our minds have a weird and wondrous way of transporting us to other places and times. You might find yourself, for instance, immersed in the
Wonderland Miami— one of the psychedelic industry’s premier annual conferences— is just around the corner. Are you ready? Just in case you aren’t here is
Establishing a digital assistance system based on artificial intelligence to support patients / Sports Medicine research group of Mainz University involved in two projects coordinated
When is a failure not a failure? Does the FDA have special rules for Sarepta Therapeutics? And how do you say “brash” in French? We
Kidney transplants are the most common organ transplant procedure in the U.S., with 25,000 taking place in 2022. But for patients who receive new kidneys,
A bipartisan group of senators this week introduced a bill that would permanently allow health providers to prescribe buprenorphine, a common medication used to treat
The share of American consumers with medical debt on their credit reports has declined dramatically over the past year as major credit rating agencies removed
More than two dozen people lined up outside a state public assistance office in Montana before it opened to ensure they didn’t get cut off
In this interview, we delve deep into the pioneering world of xenotransplantation and the evolving landscape of gene editing.